Cryoport president, CEO Shelton sells $429k in stock via 10b5-1 plan

Jerrell Shelton, President and CEO of Cryoport Inc., sold 28,800 shares of the company's stock on August 11, 2026, according to the company's 10b5-1 plan. The total sale amounted to around $429,384, with the shares traded at an average price of $14.9092 per share. The sales took place in several transactions, each priced between $14.66 and $15.16.

These sales were automatically executed following the plan Shelton established on May 11, 2026, and the plan was canceled on the same day of the sales. The stock's recent performance has been impressive, with a 76% increase in the past year and an 81% jump in the last six months, nearing its 52-week high of $16.89. Following these transactions, Shelton personally holds 1,201,814 shares of Cryoport common stock.

InvestingPro analysis suggests the stock is currently overvalued compared to its Fair Value. For more detailed insights, investors can access InvestingPro's ProTips and Pro Research Reports on the company and other US equities. Cryoport reported robust financials in its second-quarter earnings, with revenue reaching $49 million, exceeding Wall Street's projections.

The company's adjusted EBITDA stood at $400,000, signaling a step towards profitability. Operating cash flow for the first half of the year improved to $5 million, up $17 million from the prior year. The Life Sciences Services segment, a major contributor, saw a 15% year-over-year growth, generating $27.93 million, or 57% of total sales.

Despite economic and geopolitical challenges, Cryoport maintains its revenue guidance of $192 million to $196 million for the full year. These developments highlight the company's steady demand and ongoing growth, as reported by InvestingPro.